Showing results (161-170 of 259) with videos related to
Sort By:
Pageof 26
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 30, 2025
Type I Interferon Pathway Activation Disrupts Monocyte Maturation and Enhances Immune Evasion in Multiple MyelomaJian Cui, Jingwei Wang, Xiaoyun Li, et al.Annals of Hematology|February 25, 2025
The optimal time and clinical implications of measurable residual disease detection in mantle cell lymphomaYuting Yan, Yanshan Huang, Ying Yu, et al.Oncotarget|February 10, 2018
Del17p does not always significantly influence the survival of B-cell chronic lymphoproliferative disordersShuhua Yi, Zengjun Li, Dehui Zou, et al.Leukemia Research|April 22, 2014
Polyclonal serum IgM level identifies a subgroup of multiple myeloma patients with low-risk clinicobiological features and superior survivalGang An, Huijun Wang, Xiaoqi Qin, et al.Molecular Oncology|January 20, 2020
NEK2 induces autophagy-mediated bortezomib resistance by stabilizing Beclin-1 in multiple myelomaJiliang Xia, Yanjuan He, Bin Meng, et al.Blood Science (Baltimore, Md.)|May 25, 2023
Benefit of rituximab maintenance is associated with Follicular Lymphoma International Prognostic Index in patients with follicular lymphomaRu Li, Tingyu Wang, Rui Lyv, et al.Eclinicalmedicine|January 7, 2026
Ibrutinib alternating with three cycles of interval fludarabine, cyclophosphamide, and rituximab (FCR) in adults with untreated chronic lymphocytic leukaemia as time-limited regimen: a single-arm, multicentre phase 2 trial in ChinaTingyu Wang, Yuting Yan, Hui Wang, et al.Annals of Hematology|September 19, 2014
Multiple myeloma patients with low proportion of circulating plasma cells had similar survival with primary plasma cell leukemia patientsGang An, Xiaoqi Qin, Chirag Acharya, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 27, 2026
Phase II Study of BCMA Chimeric Antigen Receptor T-Cell Therapy in Patients With Newly Diagnosed Multiple Myeloma Ineligible for or Not Proceeding to Autologous Stem-Cell Transplantation (CAREMM-001)Wenqiang Yan, Chenxing Du, Rui Lv, et al.Oncotarget|November 17, 2016
Elevated neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio and decreased platelet-to-lymphocyte ratio are associated with poor prognosis in multiple myelomaLihui Shi, Xiaoqi Qin, Huijun Wang, et al.Pageof 26